Australia for Early Phase Clinical Development

Australia for Early Phase Clinical Development

05-16-2018 12:00 pm - 05-16-2018 2:00 pm


Novotech and CoSec will be onsite to discuss the advantageous Australian regulatory landscape for early phase clinical development. Fast regulatory timelines and the 43.5% research and development Tax Rebate make Australia an ideal destination for small biotech companies entering clinical trials.

Alex Ireland, MPH

Business Development Associate

Alex Ireland has been working in the biotech industry for the past five years from sales to operations, and has been working for Novotech for the past year. She is passionate about working with small-biotech companies and educating them on the benefits of running clinical trials in the Asia Pacific. Born and raised in the Bay Area, she earned a Master’s Degree from Boston Pharmaceuticals in Epidemiology and International Health.

Upcoming Event

  • A Welcome Party for Newcomers! Location: 953 Indiana Street, San Francisco

    Please join us for a celebration to welcome all new companies to the MBC BioLabs family! Come and meet the new faces in the building and enjoy some food!


953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287

Sign-Up for our Newsletter